/PRM.TO
PRM.TO Stock - Big Pharma Split Corp.
Financial Services|Asset ManagementTSX
$13.85+4.53%
+$0.60 (+4.53%) • Dec 19
75
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.81
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $15.24
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PRM.TO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$13.71 – $13.99
TARGET (TP)$15.93
STOP LOSS$12.74
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.12
52W High$14.16
52W Low$10.35
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.85M | $311,764 | $3.93M | $5.36M | $3.08M |
| Gross Profit | $1.53M | $311,764 | $3.51M | $5.00M | $589,257 |
| Gross Margin | 82.9% | 100.0% | 89.3% | 93.4% | 19.1% |
| Operating Income | $13,408 | $-139,680 | $3.15M | $4.85M | $265,423 |
| Net Income | $-538,624 | $-139,680 | $3.15M | $4.85M | $265,423 |
| Net Margin | -29.1% | -44.8% | 80.1% | 90.6% | 8.6% |
| EPS | $-0.47 | $-0.53 | $1.58 | $3.27 | $-0.22 |
Company Overview
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PRM.TOBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-1.54
Q4 2024
EPS Surprise History
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q1 23
No data
Q2 23
No data
Q4 23
No data
Q2 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Dec 31, 2024 | — | $-1.54 | — | — |
Q2 2024 | Jun 29, 2024 | — | $0.99 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.03 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.23 | — | — |
Q1 2023 | Mar 30, 2023 | — | $0.26 | — | — |
Q2 2022 | Jun 30, 2022 | — | $1.37 | — | — |
Q4 2021 | Dec 31, 2021 | — | $1.14 | — | — |
Q2 2021 | Jun 30, 2021 | — | $2.21 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.85 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.95 | — | — |
Q4 2019 | Dec 31, 2019 | — | $3.00 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.44 | — | — |
Q4 2018 | Dec 31, 2018 | — | $1.67 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.10 | — | — |
Q1 2018 | Jan 31, 2018 | — | $-0.07 | — | — |
Q2 2017 | Jun 30, 2017 | — | $0.12 | — | — |
Q1 2017 | Jan 31, 2017 | — | $0.06 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PRM.TO
What is PRM.TO's current stock price?
Big Pharma Split Corp. (PRM.TO) is currently trading at $13.85 per share. The stock has moved +4.53% today.
What is the analyst price target for PRM.TO?
No analyst price targets are currently available for this stock.
What sector is Big Pharma Split Corp. in?
Big Pharma Split Corp. operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the TSX exchange.
What is PRM.TO's market cap?
Big Pharma Split Corp. has a market capitalization of $0.02 billion, making it a small-cap company.
Does PRM.TO pay dividends?
No, Big Pharma Split Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorBNK.TO
Big Banc Split Corp.
$16.85
Mkt Cap: $0.0B
ELC.V
Elysee Development Corp.
$0.51
Mkt Cap: $0.0B
FGX.NE
Faircourt Gold Income Corp.
$6.50
Mkt Cap: $0.0B
GOAT.CN
GOAT Industries Ltd.
$0.47
Mkt Cap: $0.0B
NRC.V
Nations Royalty Corp.
$1.04
Mkt Cap: $0.0B
PXI.CN
Planet Ventures Inc.
$0.04
Mkt Cap: $0.0B
RE.V
RE Royalties Ltd.
$0.24
Mkt Cap: $0.0B
SATO.V
SATO Technologies Corp.
$0.13
Mkt Cap: $0.0B
SIX.CN
Sixty Six Capital Inc.
$0.06
Mkt Cap: $0.0B
Explore stocks similar to PRM.TO for comparison